Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,905,921
+$368,050 QoQ
Shares Held
7,574
+7.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#2,000
of 4,152 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Heritage Wealth Advisors holds $69,262,222 across 12 Drug Manufacturers - General names. ABBV ranks #3 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
244,804 | $62,172,871 | |
| 2 | MRK |
Merck & Co., Inc.
|
18,619 | $2,392,541 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
7,574 | $1,905,921 | |
| 4 | LLY |
ELI LILLY & Co
|
1,021 | $1,224,618 | |
| 5 | AMGN |
Amgen Inc
|
1,607 | $581,926 | |
| 6 | BIIB |
Biogen Inc.
|
2,009 | $434,064 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,808 | $228,422 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,250 | $72,025 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,905,921 | 7,574 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,537,871 | 7,071 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,477,873 | 6,468 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,498,989 | 6,474 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,201,332 | 6,472 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,567,628 | 7,482 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,538,348 | 8,657 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,861,841 | 9,428 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,431,334 | 8,345 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,682,968 | 9,242 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,472,989 | 9,505 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,331,702 | 8,934 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,345,144 | 9,984 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,594,337 | 10,004 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,590,080 | 9,839 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,269,492 | 9,459 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,271,074 | 8,299 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,130,717 | 6,975 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $943,467 | 6,968 | Shares | Sole | 2022-03-28 | |
| 2021-09-30 | $687,131 | 6,370 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $673,925 | 5,983 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $530,061 | 4,898 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $491,604 | 4,588 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $400,724 | 4,575 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $449,173 | 4,575 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $375,769 | 4,932 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||